MELISSA WHITE: Open Payments
NPI 1164072534 · LOUISIANA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$136 in 7 payments from 5 companies in 2025. Trend: 2023 $24 · 2024 $15 · 2025 $136
Food & beverage: $136
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $18 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: MOUNJARO, REXULTI, ENTRESTO, VRAYLAR, INGREZZA, LEQVIO.
Industry payments across MO — which companies pay providers there.
